(Q48195966)

English

Design and rationale of a 16-week adjunctive randomized placebo-controlled trial of mitochondrial agents for the treatment of bipolar depression.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25295681

Design and rationale of a 16-week adjunctive randomized placebo-controlled trial of mitochondrial agents for the treatment of bipolar depression. (English)

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25295681

placebo-controlled trial

1 reference

based on heuristic

inferred from title

bipolar depression

1 reference

based on heuristic

inferred from title

object named as

Michael Berk

13

0 references

object named as

Sue M Cotton

5

0 references

3

object named as

Gin S Malhi

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25295681

1

object named as

Olivia M Dean

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25295681

6

object named as

Seetal Dodd

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25295681

10

object named as

Nathan Dowling

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25295681

Michelle Tanious

9

object named as

Michelle Tanious

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25295681

2

object named as

Alyna Turner

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25295681

8

object named as

Yuval Samuni

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25295681

7

object named as

Jerome Sarris

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25295681

Astrid Waterdrinker

11

object named as

Astrid Waterdrinker

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25295681

12

object named as

Deidre Smith

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25295681

author name string

Chee Ng

4

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25295681

publication date

7 October 2014

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25295681

Brazilian Journal of Psychiatry

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25295681

37

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25295681

1

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25295681

3-12

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25295681

The long-term natural history of the weekly symptomatic status of bipolar I disorder

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Agomelatine adjunctive therapy for acute bipolar depression: preliminary open data

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Effectiveness of adjunctive antidepressant treatment for bipolar depression

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Mitochondrial modulators for bipolar disorder: A pathophysiologically informed paradigm for new drug development

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

The promise of N-acetylcysteine in neuropsychiatry

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18.

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

31P-MRS study of acetyl-L-carnitine treatment in geriatric depression: preliminary results

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Increased levels of a mitochondrial DNA deletion in the brain of patients with bipolar disorder.

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Quantification of total mitochondrial DNA and mitochondrial common deletion in the frontal cortex of patients with schizophrenia and bipolar disorder.

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Quantitative analysis of the 4977-bp common deletion of mitochondrial DNA in postmortem frontal cortex from patients with bipolar disorder and schizophrenia.

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Maintenance N-acetyl cysteine treatment for bipolar disorder: a double-blind randomized placebo controlled trial

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia.

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Fluorescent indicators give biased estimates of intracellular free calcium change in aggregating platelets: implication for studies with human von Willebrand factor.

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Coenzyme Q10 administration and its potential for treatment of neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Absorption, tolerability, and effects on mitochondrial activity of oral coenzyme Q10 in parkinsonian patients

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Neuroprotection by the metabolic antioxidant alpha-lipoic acid

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Excitotoxic damage, disrupted energy metabolism, and oxidative stress in the rat brain: antioxidant and neuroprotective effects of L-carnitine

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

A double-blind, randomised, controlled clinical trial of acetyl-L-carnitine vs. amisulpride in the treatment of dysthymia

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Hypo-phosphorylation of salivary peptidome as a clue to the molecular pathogenesis of autism spectrum disorders.

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Prospective predictors of suicide and suicide attempts in 1,556 patients with bipolar disorders followed for up to 2 years

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesis

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

L-carnitine improves glucose disposal in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Hiding in plain sight: uncovering a new function of vitamin A in redox signaling

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Exploring the relationship between vitamin D and basic personality traits

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Vitamin D3 enhances mood in healthy subjects during winter

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Vitamin D deficiency

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Dietary intake of fish, omega-3, omega-6 polyunsaturated fatty acids and vitamin D and the prevalence of psychotic-like symptoms in a cohort of 33,000 women from the general population

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

31P NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle.

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Ascorbic acid: much more than just an antioxidant.

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Antioxidant effects of ubiquinones in microsomes and mitochondria are mediated by tocopherol recycling

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Mitochondrial function and toxicity: role of the B vitamin family on mitochondrial energy metabolism

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

NAD+ and vitamin B3: from metabolism to therapies

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Effect of vitamin B6 on oxygen radicals, mitochondrial membrane potential, and lipid peroxidation in H2O2-treated U937 monocytes

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Effect of 2-cyclohexene-1-one-induced glutathione diminution on ischemia/reperfusion-induced alterations in the physical state of brain synaptosomal membrane proteins and lipids.

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Mood disorder with mixed features due to vitamin B(12) and folate deficiency

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

An association between subcortical dementia and pernicious anemia--a psychiatric mask

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease.

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Subtle vitamin-B12 deficiency and psychiatry: a largely unnoticed but devastating relationship?

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

A case of mania secondary to vitamin B12 deficiency.

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Folate, vitamin E, and acetyl-L-carnitine provide synergistic protection against oxidative stress resulting from exposure of human neuroblastoma cells to amyloid-beta

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Development of a Rating Scale for Primary Depressive Illness

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

The validity and internal structure of the Bipolar Depression Rating Scale: data from a clinical trial of N-acetylcysteine as adjunctive therapy in bipolar disorder

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

A rating scale for mania: reliability, validity and sensitivity

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP.

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies.

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Qualitative methods in early-phase drug trials: broadening the scope of data and methods from an RCT of N-acetylcysteine in schizophrenia

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Standardised Assessment of Personality – Abbreviated Scale (SAPAS): Preliminary validation of a brief screen for personality disorder

1 reference

https://api.crossref.org/works/10.1590%2F1516-4446-2013-1341

21 January 2018

Identifiers

10.1590/1516-4446-2013-1341

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25295681

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25295681

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48195966&oldid=2066726074"